Expression of ITM2C in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

ITM2C is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 1435.08

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

1036.9

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	3129.3
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	2562.7
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	2373.1
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	2341.6
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	2244.0
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	2125.0
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	2111.8
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	1949.4
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	1944.1
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	1859.9
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	1854.2
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	1850.1
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	1790.5
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	1754.2
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	1740.6
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	1713.4
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	1709.9
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	1707.7
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	1679.5
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	1625.4
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	1590.7
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	1563.1
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	1553.6
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	1514.5
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	1479.9
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	1478.2
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	1466.9
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	1437.3
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	1435.1
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	1430.1
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	1424.1
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	1400.4
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	1380.2
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	1378.7
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	1352.3
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	1324.5
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	1323.3
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	1319.9
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	1302.7
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	1276.9
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	1265.3
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	1250.2
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	1229.9
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	1218.1
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	1216.3
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	1203.4
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	1189.5
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	1188.9
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	1161.6
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	1157.4
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	1151.6
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	1148.3
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	1140.8
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	1132.8
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	1128.9
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	1122.7
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	1121.8
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	1081.8
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	1078.5
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	1076.9
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	1069.9
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	1044.2
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	1026.1
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	1020.7
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	1020.3
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	1018.5
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	1005.9
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	991.9
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	967.4
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	960.3
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	953.5
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	953.0
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	949.6
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	945.4
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	932.8
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	932.3
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	895.5
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	884.9
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	876.4
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	873.5
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	858.7
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	850.1
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	843.5
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	840.6
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	840.1
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	836.0
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	834.3
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	804.8
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	796.8
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	795.7
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	788.5
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	785.0
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	778.4
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	773.1
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	760.2
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	750.0
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	738.5
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	730.3
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	716.7
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	716.7
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	707.5
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	695.9
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	688.7
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	680.7
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	663.2
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	662.8
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	662.2
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	645.6
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	631.7
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	626.4
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	623.2
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	616.3
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	605.1
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	592.9
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	567.0
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	556.1
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	542.6
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	533.5
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	530.7
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	528.8
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	505.6
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	479.5
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	471.6
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	451.6
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	443.1
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	396.0
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	391.2
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	353.4
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	340.5
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	331.5
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	326.0
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	313.5
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	311.9
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	304.5
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	299.4
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	283.2
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	273.3
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	219.8
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	173.5
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	144.8
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	108.2
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

ITM2C is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 515.85

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

846.8

Number of samples

Samples

Sample	Description	pTPM
AK165	N, NA, stage:NA, alive, 360 days	2577.2
AK091	N, NA, stage:NA, dead, 210 days	2408.2
AK006	N, NA, stage:NA, dead, 360 days	1886.1
AK167	N, NA, stage:NA, dead, 180 days	1738.7
AK158	N, NA, stage:NA, dead, 360 days	1713.7
AK051	N, NA, stage:NA, dead, 360 days	1646.7
AK071	N, NA, stage:NA, dead, 540 days	1575.4
AK183	N, NA, stage:NA, alive, 360 days	1514.8
AK236	N, NA, stage:NA, dead, 360 days	1399.7
AK199	N, NA, stage:NA, alive, 1860 days	1392.2
AK053	N, NA, stage:NA, dead, 300 days	1341.3
AK079	N, NA, stage:NA, dead, 210 days	1341.2
AK134	N, NA, stage:NA, dead, 360 days	1331.3
AK049	N, NA, stage:NA, dead, 180 days	1249.6
AK089	N, NA, stage:NA, dead, 330 days	1216.2
AK117	N, NA, stage:NA, dead, 210 days	1088.8
AK055	N, NA, stage:NA, dead, 240 days	1042.6
AK076	N, NA, stage:NA, alive, 660 days	972.9
AK088	N, NA, stage:NA, dead, 360 days	964.4
AK005	N, NA, stage:NA, dead, 240 days	917.3
AK216	N, NA, stage:NA, dead, 360 days	901.4
AK149	N, NA, stage:NA, dead, 420 days	869.2
AK100	N, NA, stage:NA, alive, 960 days	849.7
AK074	N, NA, stage:NA, alive, 300 days	809.6
AK173	N, NA, stage:NA, dead, 180 days	804.0
AK098	N, NA, stage:NA, dead, 660 days	782.2
AK213	N, NA, stage:NA, alive, 2010 days	712.0
AK035	N, NA, stage:NA, dead, 210 days	687.2
AK231	N, NA, stage:NA, dead, 240 days	685.1
AK227	N, NA, stage:NA, alive, 300 days	677.8
AK133	N, NA, stage:NA, dead, 360 days	636.6
AK081	N, NA, stage:NA, dead, 180 days	619.3
AK188	N, NA, stage:NA, alive, 420 days	612.7
AK003	N, NA, stage:NA, dead, 600 days	600.2
AK218	N, NA, stage:NA, dead, 180 days	586.3
AK099	N, NA, stage:NA, dead, 420 days	586.1
AK142	N, NA, stage:NA, alive, 90 days	549.3
AK123	N, NA, stage:NA, dead, 180 days	538.2
AK139	N, NA, stage:NA, dead, 270 days	534.3
AK178	N, NA, stage:NA, dead, 240 days	530.6
AK103	N, NA, stage:NA, alive, 1320 days	501.1
AK066	N, NA, stage:NA, alive, 960 days	483.5
AK156	N, NA, stage:NA, dead, 330 days	475.9
AK015	N, NA, stage:NA, alive, 720 days	473.0
AK043	N, NA, stage:NA, alive, 660 days	428.9
AK185	N, NA, stage:NA, alive, 330 days	409.4
AK226	N, NA, stage:NA, dead, 360 days	380.6
AK072	N, NA, stage:NA, dead, 150 days	362.6
AK002	N, NA, stage:NA, dead, 570 days	359.4
AK195	N, NA, stage:NA, dead, 390 days	357.5
AK068	N, NA, stage:NA, alive, 360 days	355.1
AK085	N, NA, stage:NA, alive, 660 days	313.0
AK030	N, NA, stage:NA, dead, 120 days	298.9
AK124	N, NA, stage:NA, alive, 1920 days	260.7
AK153	N, NA, stage:NA, dead, 240 days	252.2
AK102	N, NA, stage:NA, alive, 1740 days	234.6
AK205	N, NA, stage:NA, dead, 120 days	171.9
AK041	N, NA, stage:NA, alive, 810 days	108.4
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0175060003	Tumor	1.0
CPT0093510003	Tumor	1.0
CPT0167860004	Tumor	1.0
CPT0189650004	Tumor	0.9
CPT0182580003	Tumor	0.8
CPT0189750004	Tumor	0.8
CPT0002410011	Tumor	0.8
CPT0209440003	Tumor	0.7
CPT0190360004	Tumor	0.7
CPT0204360003	Normal	0.6
CPT0104220003	Tumor	0.6
CPT0217880003	Tumor	0.6
CPT0064650003	Tumor	0.6
CPT0093590003	Tumor	0.5
CPT0206450003	Tumor	0.5
CPT0171580008	Tumor	0.5
CPT0201710003	Tumor	0.5
CPT0079790003	Tumor	0.5
CPT0189850004	Tumor	0.5
CPT0162140003	Tumor	0.5
CPT0087730003	Tumor	0.5
CPT0224540004	Tumor	0.5
CPT0168720003	Tumor	0.4
CPT0168270003	Tumor	0.4
CPT0218890004	Tumor	0.4
CPT0092440003	Tumor	0.4
CPT0199770003	Tumor	0.4
CPT0204340003	Normal	0.4
CPT0206330003	Tumor	0.4
CPT0125510003	Tumor	0.3
CPT0167640003	Tumor	0.3
CPT0204370003	Normal	0.3
CPT0168830003	Tumor	0.3
CPT0224600003	Tumor	0.3
CPT0168590003	Tumor	0.3
CPT0186100003	Tumor	0.3
CPT0205890003	Tumor	0.3
CPT0127420003	Tumor	0.3
CPT0125220003	Tumor	0.3
CPT0189250003	Tumor	0.3
CPT0161730003	Tumor	0.2
CPT0196850003	Tumor	0.2
CPT0204410003	Normal	0.2
CPT0189460003	Tumor	0.2
CPT0225730003	Tumor	0.2
CPT0206880003	Tumor	0.2
CPT0205670004	Tumor	0.2
CPT0204400003	Normal	0.1
CPT0204380003	Normal	0.1
CPT0167750004	Tumor	0.1
CPT0206110003	Tumor	0.1
CPT0087680003	Tumor	0.1
CPT0217060003	Tumor	0.1
CPT0087570003	Tumor	0.1
CPT0221180003	Tumor	0.1
CPT0204330003	Normal	0.1
CPT0224330003	Tumor	0.1
CPT0204420003	Normal	0.1
CPT0204350003	Normal	0.1
CPT0218960004	Tumor	0.1
CPT0224390004	Tumor	0.1
CPT0071100003	Tumor	0.0
CPT0182550003	Tumor	0.0
CPT0218830004	Tumor	0.0
CPT0182500003	Tumor	0.0
CPT0093360003	Tumor	0.0
CPT0207030003	Tumor	0.0
CPT0204390003	Normal	0.0
CPT0206780003	Tumor	0.0
CPT0167970003	Tumor	0.0
CPT0219080004	Tumor	0.0
CPT0208980003	Tumor	0.0
CPT0206670004	Tumor	0.0
CPT0205450004	Tumor	0.0
CPT0218670003	Tumor	-0.1
CPT0207090003	Tumor	-0.1
CPT0093550003	Tumor	-0.1
CPT0104330003	Tumor	-0.2
CPT0125570003	Tumor	-0.2
CPT0225760003	Tumor	-0.2
CPT0064890003	Tumor	-0.2
CPT0228220003	Tumor	-0.3
CPT0206000004	Tumor	-0.3
CPT0168380003	Tumor	-0.3
CPT0167530003	Tumor	-0.3
CPT0217190003	Tumor	-0.3
CPT0205570003	Tumor	-0.3
CPT0078580003	Tumor	-0.4
CPT0217430008	Tumor	-0.5
CPT0168480003	Tumor	-0.5
CPT0217710008	Tumor	-0.6
CPT0217100003	Tumor	-0.6
CPT0168080003	Tumor	-0.6
CPT0217000004	Tumor	-0.6
CPT0162100003	Tumor	-0.6
CPT0216920008	Tumor	-0.6
CPT0087950003	Tumor	-0.7
CPT0162020003	Tumor	-0.7
CPT0127480003	Tumor	-0.7
CPT0218690004	Tumor	-0.7
CPT0205780003	Tumor	-0.8
CPT0190240004	Tumor	-0.8
CPT0218330004	Tumor	-0.8
CPT0189570004	Tumor	-0.8
CPT0123530003	Tumor	-0.8
CPT0218770003	Tumor	-0.9
CPT0206230003	Tumor	-0.9
CPT0089150003	Tumor	-1.0
CPT0093450003	Tumor	-1.3
CPT0206560003	Tumor	-2.1
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis